Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With more drugmakers in line to launch the drug soon, the prices may see a further erosion. Sohini Das reports. IMAGE: An......
Drug major Cipla on Tuesday said it has launched drone-powered deliveries of critical medicines – cardiac, respiratory and other essential chronic therapies – to hospitals and......
India’s third-largest pharmaceutical company by revenue, Cipla, is up for grabs in a three-way fight between Torrent Pharmaceuticals, Dr Reddy’s Laboratories (DRL) and private equity......
In one of the largest potential transactions this year, private-equity majors Blackstone and Baring have initiated talks with the Hamied family, the promoters of pharmaceutical firm Cipla, to......
India’s largest listed pharmaceutical (pharma) company — Sun Pharmaceutical Industries (Sun Pharma) — is expected to maintain its outperformance vis-à-vis the......
Analysts have turned cautious on Cipla, as the recently issued form 483 by the US FDA with eight observations to its Pithampur (Indore) plant is expected to delay the launch of the company’s......